On The Web![[search]](http://wwwcache.wral.com/presentation/v1/images/icons/16x12/search-form-icon.gif){kind=icon}
Site SearchDULUTH, Ga. — Cellutions, a startup focused on medical devices and procedures to treat cellulite, has closed on $7 million in new funding, according to VentureWire.
The company, which was formed in 2004, landed Versant Ventures as a new investor. Existing investors Carlyle Venture partners and SV Life Sciences also participated.
Cellutions raised a $5.6 million Series A round for proof of concept and feasibility studies.
According to the firm’s Web site, cellulite affects 90 percent of post-adolescent females. Its proposed technology and procedure would be performed on an outpatient basis in what the company calls a “lunchtime” treatment.
Georgia Firm Secures $7M in New Financing to Battle Cellulite
Copyright 2007 by Capitol Broadcasting Company. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
News Alerts to your Email & Cell Phone-
- PC makers may face a legal challenge in ‘Green Dam’ battle from U.S. firm
Jul. 3, 2009 - As Nortel’s final demise nears, what blame should its board shoulder?
Jul. 3, 2009 - Climate change and the economy: Public policies like ‘cap and trade’ and a carbon tax could have big impacts on our wallets.
Jul. 3, 2009 - 20/20: Surgery can let you see like a child again
Jul. 3, 2009 |
- CDC: US swine flu cases rise to nearly 34,000
Jul. 3, 2009
- PC makers may face a legal challenge in ‘Green Dam’ battle from U.S. firm
-
- RTP-based Metabolon raises another $1 million in venture capital
Jul. 2, 2009 - NanoCor Therapeutics raises $2.5M
Jul. 1, 2009 - Despite three IPOs, venture-backed exits drop to trickle in second quarter
Jul. 1, 2009 - Seeking investors? Be sure to find the right angel partners
Jul. 1, 2009 - Georgia Research Alliance venture fund closes on $18.75 million
Jun. 29, 2009
- RTP-based Metabolon raises another $1 million in venture capital
More from wrallocaltechwire.com
Market Watch
advertisement